Not logged in Share Save
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi- Institutional Based survey of Adjuvant and fi rst-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) Reni, M.; Milella, M.; Bergamo, F.; Di Marco, M.; Giommoni, E.; Cardellino, G. G.; Cavanna, L.; Bonomi, M.; Zustovich, F.; Bozzarelli, S.; Salmaso, F.; Spada, M.; Orsi, G.; Macchini, M.; Insolda, J.; Procaccio, L.; Santoni, A.; De Simone, I.; Caldirola, L.; Galli, F.; Pinto, C. Share Save
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey Reni, M.; Giommoni, E.; Bergamo, F.; Cavanna, L.; Simionato, F.; Spada, M.; Di Marco, M.; Bernardini, I.; Cordio, S. S.; Latiano, T.; Spallanzani, A.; Silvestris, N.; Cardellino, G. G.; Bonomi, M.; Milella, M.; Luchena, G.; Tamburini, E.; Macchini, M.; Orsi, G.; Modesti, M.; Procaccio, L.; Santoni, A.; De Simone, I.; Caldirola, L.; Galli, F.; Pinto, C. Share Save
Non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) guideline application in real-world: MultiInstitutional based survey of adjuvant and first-line pancreatic ductal adenocarcinoma treatment in Italy (GARIBALDI) Pinto, C.; Milella, M.; Bergamo, F.; Di Marco, M. C.; Cardellino, G. G.; Cavanna, L.; Giommoni, E.; Zustovich, F.; Bonomi, M.; Bozzarelli, S.; Vicario, G.; Parlagreco, E.; Frassineti, G. L.; Macchini, M.; Orsi, G.; Santoni, A.; Caldirola, L.; De Simone, I.; Reni, M. Share Save
Krukenberg Tumor Related to Gallbladder Cancer in a Young Woman: A Case Report and Review of the Literature Grizzi, Giulia; Ghidini, Michele; Ratti, Margherita; D'Ercole, Marianna; Tanzi, Giulia; Abbiati, Annalisa; Celotti, Andrea; Spada, Daniele; Baiocchi, Gian Luca; Bonomi, Maria Share Save
Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies Grizzi, Giulia; Venetis, Kostantinos; Denaro, Nerina; Bonomi, Maria; Celotti, Andrea; Pagkali, Antonia; Hahne, Jens Claus; Tomasello, Gianluca; Petrelli, Fausto; Fusco, Nicola; Ghidini, Michele Share Save
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma Canova, S.; Ceresoli, G. L.; Grosso, F.; Zucali, P. A.; Gelsomino, F.; Pasello, G.; Mencoboni, M.; Rulli, E.; Galli, F.; De Simone, I.; Carlucci, L.; De Angelis, A.; Belletti, M.; Bonomi, M.; D'Aveni, A.; Perrino, M.; Bono, F.; Cortinovis, D. L. Share Save
Share Save
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer Rossi, Sabrina; Finocchiaro, Giovanna; Di Noia, Vincenzo; Bonomi, Maria; Cerchiaro, Eleonora; De Rose, Fiorenza; Franceschini, Davide; Navarria, Pierina; Ceresoli, Giovanni Luca; Beretta, Giordano Domenico; D'Argento, Ettore; Scorsetti, Marta; Santoro, Armando; Toschi, Luca Share Save
Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors Rossi, Sabrina; Toschi, Luca; Finocchiaro, Giovanna; Di Noia, Vincenzo; Bonomi, Maria; Cerchiaro, Eleonora; Ceresoli, Giovanni Luca; Beretta, Giordano Domenico; D'Argento, Ettore; Santoro, Armando Share Save
Share Save
Share Save
Share Save
Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience Bonomi, M.; Bonomi, L.; Sauta, M. G.; Bettini, A. C.; Squadroni, M.; Brena, F.; Cerchiaro, E.; Ripa, C.; Salvini, P.; Beretta, G. D.; Tondini, C.; Ceresoli, G. L. Share Save
Weekly cisplatin, leucovorin and 5Fluorouracile (PFL) as first line chemotherapy in selected patients with advanced gastric cancer Squadroni, M.; Brena, F.; Cerchiaro, E.; Bonomi, M.; Sauta, M. G.; Ripa, C.; Ceresoli, G.; Salvini, P.; Beretta, G. Share Save
Share Save
Share Save
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer Rayson, Daniel; Lupichuk, Sasha; Potvin, Kylea; Dent, Susan; Shenkier, Tamara; Dhesy-Thind, Sukhbinder; Ellard, Susan L.; Prady, Catherine; Salim, Muhammad; Farmer, Patricia; Allo, Ghasson; Tsao, Ming-Sound; Allan, Alison; Ludkovski, Olga; Bonomi, Maria; Tu, Dongsheng; Hagerman, Linda; Goodwin, Rachel; Eisenhauer, Elizabeth; Bradbury, Penelope Share Save
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis Bria, Emilio; Massari, Francesco; Maines, Francesca; Pilotto, Sara; Bonomi, Maria; Porta, Camillo; Bracarda, Sergio; Heng, Daniel; Santini, Daniele; Sperduti, Isabella; Giannarelli, Diana; Cognetti, Francesco; Tortora, Giampaolo; Milella, Michele Share Save
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials Bria, Emilio; Carbognin, Luisa; Furlanetto, Jenny; Pilotto, Sara; Bonomi, Maria; Guarneri, Valentina; Vicentini, Cecilia; Brunelli, Matteo; Nortilli, Rolando; Pellini, Francesca; Sperduti, Isabella; Giannarelli, Diana; Pollini, Giovanni Paolo; Conte, Pierfranco; Tortora, Giampaolo Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}